share_log

2024年6月21日舉行的股東週年大會投票結果

POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 21, 2024

Hong Kong Stock Exchange ·  Jun 21 18:00
Summary by Futu AI
京东健康於2024年6月21日召開股東週年大會，會上所有提呈決議案均獲正式通過。該公司已發行股份總數為3,189,465,111股，其中47,290,140股未歸屬獎勵股份由受託人持有並放棄投票。有效投票股份總數為3,142,174,971股。會議通過包括接收並採納2023年度經審計合併財務報表、董事及審計師報告，以及重選李玲女士、張吉豫博士、陳興垚先生為獨立非執行董事等決議。此外，授權董事會釐定董事薪酬，重新委任德勤會計師行為審計師，並授予董事一般授權以配發、發行及處理公司普通股。特別決議案中，股東批准採納公司第七次經修訂及重述之組織章程大綱及章程細則，並即時生效。董事會成員金恩林先生、Qingqing Yi先生、李玲女士、張吉豫博士、陳興垚先生及吳鷹先生出席會議，劉強東先生因其他公務缺席。
京东健康於2024年6月21日召開股東週年大會，會上所有提呈決議案均獲正式通過。該公司已發行股份總數為3,189,465,111股，其中47,290,140股未歸屬獎勵股份由受託人持有並放棄投票。有效投票股份總數為3,142,174,971股。會議通過包括接收並採納2023年度經審計合併財務報表、董事及審計師報告，以及重選李玲女士、張吉豫博士、陳興垚先生為獨立非執行董事等決議。此外，授權董事會釐定董事薪酬，重新委任德勤會計師行為審計師，並授予董事一般授權以配發、發行及處理公司普通股。特別決議案中，股東批准採納公司第七次經修訂及重述之組織章程大綱及章程細則，並即時生效。董事會成員金恩林先生、Qingqing Yi先生、李玲女士、張吉豫博士、陳興垚先生及吳鷹先生出席會議，劉強東先生因其他公務缺席。
JD Health held its annual shareholder meeting on June 21, 2024, during which all proposed resolutions were approved. The company has issued a total of 3,189,465,111 shares, of which 47,290,140 shares of unattributed award shares are held by a trustee and waived voting rights. The total number of valid voting shares is 3,142,174,971. The meeting passed resolutions including the acceptance and adoption of the audited consolidated financial statements for the fiscal year 2023, the director and auditor's report, and the reelection of Ms. Li Ling, Dr. Zhang Jiyu, and Mr. Chen Xingyao as independent non-executive directors. In addition, the board of directors was authorized to determine director remuneration, reappoint Deloitte as auditor, and grant general authority to directors for the issuance, offering, and handling...Show More
JD Health held its annual shareholder meeting on June 21, 2024, during which all proposed resolutions were approved. The company has issued a total of 3,189,465,111 shares, of which 47,290,140 shares of unattributed award shares are held by a trustee and waived voting rights. The total number of valid voting shares is 3,142,174,971. The meeting passed resolutions including the acceptance and adoption of the audited consolidated financial statements for the fiscal year 2023, the director and auditor's report, and the reelection of Ms. Li Ling, Dr. Zhang Jiyu, and Mr. Chen Xingyao as independent non-executive directors. In addition, the board of directors was authorized to determine director remuneration, reappoint Deloitte as auditor, and grant general authority to directors for the issuance, offering, and handling of company common stock. in a special resolution, shareholders voted to adopt the seventh amended and restated outline and bylaws of the Company's Charter, which will take immediate effect. Members of the board of directors, including Mr. Jin Enlin, Mr. Qingqing Yi, Ms. Li Ling, Dr. Zhang Jiyu, Mr. Chen Xingyao, and Mr. Wu Ying attended the meeting, while Mr. Liu Qiangdong was absent due to other official duties.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.